A new once-a-week drug may be as good as insulin in controlling diabetes, according to research.
A study conducted by the drug’s manufacturer, GlaxoSmithKline, showed that albiglutide reduced blood-sugar levels as much as insulin over a period of 26 weeks.
Blood-sugar levels dropped 0.82 percent for patients on the drug, while research subjects taking insulin saw a drop of 0.82 percent. Patients in the study also lost an average of 1.6 pounds, while the patients on insulin gained 1.8 pounds.
A similar drug, Bydureon, is now on the market after a 12-year approval process with the federal Food and Drug Administration.
GlaxoSmithKline said that albiglutide may be on the market by 2013.
Free Diabetic Recipe Book
Get your free meal guide and recipe booklet today, packed with more than 60 recipes to help you or your loved ones better manage diabetes symptoms.
Click here to get yours!
